Drawing for COSTCHECK

USPTO serial 97853121

COSTCHECK

Reviewed by CopyMark Law Group

Reg. 8503564Status 700Registered
Filing date
Status date
Registration date
Oct 13, 2026
Examiner
XU, ELAINE YILIN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with COSTCHECK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Gregory B. Phillips

Gregory B. Phillips KNOBBE, MARTENS, OLSON & BEAR LLP2040 MAIN STREET, 14TH FLOORIRVINE, CA 92614United States

Goods and services

ClassDescriptionStatusFirst use
035Electronic data collection, management, analysis, and display services being a form of analysis of market research data through data visualization for business purposes, namely, in the fields of medicine, healthcare, pharmaceuticals, and biotechnology; Business services provided to the medical, healthcare, pharmaceutical, and biotechnology industries, namely, the collection, reporting, and analysis of healthcare and pharmaceutical quality data for business purposesACTIVE—
042Data Warehousing; Providing temporary use of non-downloadable computer software for supply chain management of pharmaceuticals, vaccines, and medications; Providing temporary use of non-downloadable computer software for monitoring purchasing trends and pricing for pharmaceuticals, vaccines, and medications; Providing temporary use of non-downloadable computer software for providing information regarding cost-effective alternatives and products for pharmaceuticals, vaccines, and medications; Providing temporary use of non-downloadable computer software for providing information and recommendations regarding purchasing pharmaceuticals, vaccines, and medications; Providing temporary use of non-downloadable computer software for providing information and recommendations regarding cost-effective alternatives and products in connection with purchasing pharmaceuticals, vaccines, and medications; Providing temporary use of non-downloadable computer software for providing information and recommendations regarding cost-effective alternative suppliers in connection with purchasing pharmaceuticals, vaccines, and medications; Providing temporary use of non-downloadable computer software for providing information and recommendations regarding alternatives to help alleviate or respond to pharmaceutical, vaccine and medication shortages; Providing temporary use of non-downloadable computer software for providing information and recommendations regarding compliance with contracts, discount programs, and rebates in connection with purchasing pharmaceuticals, vaccines, and medications; Providing temporary use of non-downloadable computer software for assessing, reviewing, and auditing prescription and medication records; Providing temporary use of non-downloadable computer software for assessing, reviewing, and auditing prescription and medication records in connection with purchase pricing, budgeting, discounts, and rebates; Providing temporary use of non-downloadable computer software for assessing, reviewing, and auditing prescription and medication records in connection with contract compliance and Group Purchasing Organizations (GPO) compliance; Providing temporary use of non-downloadable computer software for assessing, reviewing and reporting data trends found in prescription and medication records; Providing temporary use of non-downloadable computer software for monitoring, tracking, and taking inventory of pharmaceuticals, vaccines, and medications; Software as a service (SAAS) services featuring software for use in supply chain management of pharmaceuticals, vaccines, and medications; Software as a service (SAAS) services featuring software for monitoring purchasing trends and pricing for pharmaceuticals, vaccines, and medications; Software as a service (SAAS) services featuring software for providing information regarding cost-effective alternatives and products for pharmaceuticals, vaccines, and medications; Software as a service (SAAS) services featuring software for providing information and recommendations regarding purchasing pharmaceuticals, vaccines, and medications; Software as a service (SAAS) services featuring software for providing information and recommendations regarding cost-effective alternatives and products in connection with purchasing pharmaceuticals, vaccines, and medications; Software as a service (SAAS) services featuring software for providing information and recommendations regarding cost-effective alternative suppliers in connection with purchasing pharmaceuticals, vaccines, and medications; Software as a service (SAAS) services featuring software for providing information and recommendations regarding alternatives to help alleviate or respond to pharmaceutical, vaccine and medication shortages; Software as a service (SAAS) services featuring software for providing information and recommendations regarding compliance with contracts, discount programs, and rebates in connection with purchasing pharmaceuticals, vaccines, and medications; Software as a service (SAAS) services featuring software for assessing, reviewing, and auditing prescription and medication records; Software as a service (SAAS) services featuring software for assessing, reviewing, and auditing prescription and medication records in connection with purchase pricing, budgeting, discounts, and rebates; Software as a service (SAAS) services featuring software for assessing, reviewing, and auditing prescription and medication records in connection with contract compliance and Group Purchasing Organizations (GPO) compliance; Software as a service (SAAS) services featuring software for assessing, reviewing and reporting data trends found in prescription and medication records; Software as a service (SAAS) services featuring software for monitoring, tracking, and taking inventory of pharmaceuticals, vaccines, and medicationsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 13, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 13, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 21, 2026SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Sep 21, 2026CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
May 12, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Dec 30, 2025IUAFUSE AMENDMENT FILED—
Dec 30, 2025EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Nov 13, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 12, 2025EX2GSOU EXTENSION 2 GRANTED—
Nov 12, 2025EXT2SOU EXTENSION 2 FILED—
Nov 12, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 19, 2025EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
May 19, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 19, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 19, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 2, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 2, 2025EX1GSOU EXTENSION 1 GRANTED—
May 2, 2025EXT1SOU EXTENSION 1 FILED—
May 1, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 12, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 17, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 17, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 28, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 9, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 14, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 14, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 14, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 14, 2024XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Mar 14, 2024XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Jan 3, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 3, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 3, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 18, 2023DOCKASSIGNED TO EXAMINER—
Sep 20, 2023ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Apr 14, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 27, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance